| Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies S Moriguchi, A Takamiya, Y Noda, N Horita, M Wada, S Tsugawa, ... Molecular psychiatry 24 (7), 952-964, 2019 | 292 | 2019 |
| Kynurenine pathway in depression: A systematic review and meta-analysis K Ogyu, K Kubo, Y Noda, Y Iwata, S Tsugawa, Y Omura, M Wada, ... Neuroscience & Biobehavioral Reviews 90, 16-25, 2018 | 267 | 2018 |
| Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies T Nakahara, S Tsugawa, Y Noda, F Ueno, S Honda, M Kinjo, H Segawa, ... Molecular psychiatry 27 (1), 744-757, 2022 | 109 | 2022 |
| Effectiveness of the prefrontal repetitive transcranial magnetic stimulation on cognitive profiles in depression, schizophrenia, and Alzheimer's disease: a systematic review T Iimori, S Nakajima, T Miyazaki, R Tarumi, K Ogyu, M Wada, S Tsugawa, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 88, 31-40, 2019 | 96 | 2019 |
| Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis Y Mimura, H Nishida, S Nakajima, S Tsugawa, S Morita, K Yoshida, ... Neuroscience & Biobehavioral Reviews 121, 47-59, 2021 | 78 | 2021 |
| Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis S Tsugawa, Y Noda, R Tarumi, Y Mimura, K Yoshida, Y Iwata, M Elsalhy, ... Journal of Psychopharmacology 33 (10), 1199-1214, 2019 | 74 | 2019 |
| Motor cortex excitability and inhibitory imbalance in autism spectrum disorder assessed with transcranial magnetic stimulation: a systematic review F Masuda, S Nakajima, T Miyazaki, K Yoshida, S Tsugawa, M Wada, ... Translational psychiatry 9 (1), 110, 2019 | 71 | 2019 |
| Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment M Wada, Y Noda, Y Iwata, S Tsugawa, K Yoshida, H Tani, Y Hirano, ... Molecular Psychiatry 27 (7), 2950-2967, 2022 | 66 | 2022 |
| Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study R Tarumi, S Tsugawa, Y Noda, E Plitman, S Honda, K Matsushita, ... Neuropsychopharmacology 45 (4), 632-640, 2020 | 63 | 2020 |
| Effect of education on Alzheimer’s disease-related neuroimaging biomarkers in healthy controls, and participants with mild cognitive impairment and Alzheimer’s disease: a cross … M Wada, Y Noda, S Shinagawa, JK Chung, K Sawada, K Ogyu, R Tarumi, ... Journal of Alzheimer's Disease 63 (2), 861-869, 2018 | 56 | 2018 |
| The P300 event-related potential in bipolar disorder: a systematic review and meta-analysis M Wada, S Kurose, T Miyazaki, S Nakajima, F Masuda, Y Mimura, ... Journal of affective disorders 256, 234-249, 2019 | 49 | 2019 |
| Transcranial magnetic stimulation neurophysiology of patients with major depressive disorder: a systematic review and meta-analysis M Kinjo, M Wada, S Nakajima, S Tsugawa, T Nakahara, DM Blumberger, ... Psychological medicine 51 (1), 1-10, 2021 | 38 | 2021 |
| Neural correlates of delay discount alterations in addiction and psychiatric disorders: a systematic review of magnetic resonance imaging studies Y Noda, MS Barr, M ElSalhy, F Masuda, R Tarumi, K Ogyu, M Wada, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 99, 109822, 2020 | 35 | 2020 |
| White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: a diffusion tensor imaging study R Ochi, Y Noda, S Tsuchimoto, R Tarumi, S Honda, K Matsushita, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 100, 109871, 2020 | 33 | 2020 |
| Clinical effectiveness of repetitive transcranial magnetic stimulation treatment in children and adolescents with neurodevelopmental disorders: A systematic review F Masuda, S Nakajima, T Miyazaki, R Tarumi, K Ogyu, M Wada, ... Autism 23 (7), 1614-1629, 2019 | 30 | 2019 |
| Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysis F Ueno, Y Iwata, S Nakajima, F Caravaggio, JM Rubio, G Horga, ... Neuroscience & Biobehavioral Reviews 132, 1205-1213, 2022 | 27 | 2022 |
| Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: a multi-atlas segmentation study T Takahashi, S Tsugawa, S Nakajima, E Plitman, MM Chakravarty, ... Schizophrenia Research 243, 268-275, 2022 | 24 | 2022 |
| Gamma‐aminobutyric acid (GABA) levels in the midcingulate cortex and clozapine response in patients with treatment‐resistant schizophrenia: A proton magnetic resonance … F Ueno, S Nakajima, Y Iwata, S Honda, E Torres‐Carmona, W Mar, ... Psychiatry and Clinical Neurosciences 76 (11), 587-594, 2022 | 19 | 2022 |
| Investigating structural subdivisions of the anterior cingulate cortex in schizophrenia, with implications for treatment resistance and glutamatergic levels R Ochi, E Plitman, R Patel, R Tarumi, Y Iwata, S Tsugawa, J Kim, S Honda, ... Journal of Psychiatry and Neuroscience 47 (1), E1-E10, 2022 | 17 | 2022 |
| Approach‐oriented coping strategy level may be related to volume of the whole hippocampus in the elderly H Kida, S Nakajima, R Shikimoto, R Ochi, Y Noda, S Tsugawa, S Fujii, ... Psychiatry and Clinical Neurosciences 74 (4), 270-276, 2020 | 16 | 2020 |
